Catalyst Wire Dossier Catalyst Wire Dossier

Supaglutide

· Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Supaglutide, covering 2021-09-17 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2) [Phase 2, Phase 3]

See pricing